Kalaris Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $190.8M
Liabilities Breakdown FY2023
Total Liabilities: $45.0M
Asset Breakdown
Total Assets: $190.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $90.1M | 47.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $100.7M | 52.8% |
Liabilities Breakdown
Total Liabilities: $45.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.8M | 15.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $38.3M | 85.0% |